Skip to content

Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS)

Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS), Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04717037
Acronym
OMEPS
Enrollment
300
Registered
2021-01-20
Start date
2020-09-01
Completion date
2022-08-01
Last updated
2021-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late-Onset Neonatal Sepsis, Pre-Term, Sepsis

Keywords

Olive oil, Massage, Preterm, Late-Onset sepsis

Brief summary

The OMEPS trial is a randomized clinical trial in the western region of Saudi Arabia. Conducted to assess the safety and feasibility of olive oil as massage for preterm infants and if associated with reduced risk of Late-Onset sepsis.

Interventions

BIOLOGICALOlive Oil Massage

olive oil massage application.

Sponsors

King Abdulaziz University
CollaboratorOTHER
King Abdullah International Medical Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
24 Weeks to 32 Weeks
Healthy volunteers
No

Inclusion criteria

1. Preterm infants born at one of the participated centers. 2. Preterm Infants born at ≥24weeks gestation and ≤32weeks gestation 3. Birth weight ≥ 500gm up to 2000 gm.

Exclusion criteria

1. Outborn Infants. 2. Preterm infants \< 24wk or \> 32 wk 3. Preterm infants \< 500 gm or \> 2000gm 4. Critically ill patients, e.g., Hemodynamic unstable, culture-confirmed neonatal sepsis, Hydrops fetalis, Life-threatening congenital anomalies. 5. Congenital skin anomalies or infection 6. Major surgical procedure 7. Any patient whose parents refuse consent. 8. Death within 48 hours of life.

Design outcomes

Primary

MeasureTime frameDescription
Rate of culture-proven sepsis in the blood or CSF72 hours from birth till 28 days of lifePrimary outcomes defined as the rate of culture-proven sepsis in the blood or CSF in the 28 days of life.Late-onset sepsis defined as sepsis onset after 72 h of life. The olive oil will be applied initially at 72 hours of life then twice daily with a dose of 4ml/kg.

Secondary

MeasureTime frameDescription
Neonatal Skin Condition score72 hours from birth till 28 days of lifeValidated Scoring system \[ Neonatal Skin Condition Score \] will be used to score the skin integrity, and care will be monitored at baseline then weekly till age 28th of life or discharge. Skin condition was assessed with the Neonatal Skin Condition Score,This score has 9 scores from 1 to 9, 1 depicting the best skin state and 9 the worst with erythema, blistering & oozing over the entire area.

Countries

Saudi Arabia

Contacts

Primary ContactJubara Alallah
AlallahJS@ngha.med.sa966554688775

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026